宫腔组织切除系统治疗宫腔良性占位病变的临床分析  

Clinical analysis of the hysteroscopic tissue removal system for treating intrauterine benign occupying lesions of patients

作　　者：韩宇新 刘硕[2] 郑文佩 邹倩[3] HAN Yuxin;LIU Shuo;ZHENG Wenpei;ZOU Qian(Wuhan University of Science and Technology Hubei Provincial Maternal and Child Health Hos pital Graduate Joint Training Base,Wuhan,Hubei Province,430070;School of Medicine,Faculty of Medicine,Wuhan Univer-sity of Science and Technology,Wuhan;Hubei Maternal and Child Health Care Hospital,Wuhan)

机构地区：[1]武汉科技大学湖北省妇幼保健院研究生联合培养基地,430070 [2]武汉科技大学医学部医学院 [3]湖北省妇幼保健院

出　　处：《中国计划生育学杂志》2024年第9期2117-2121,共5页Chinese Journal of Family Planning

基　　金：湖北省卫生健康委员会联合基金项目(WJ2019H274)。

摘　　要：目的:探讨宫腔组织切除系统(MyoSure)治疗宫腔良性占位病变的安全性和有效性。方法:回顾性分析2013年8月-2023年3月于湖北省妇幼保健院行MyoSure治疗的宫腔良性占位病变患者152例临床资料,其中子宫粘膜下肌瘤108例、子宫内膜息肉29例、宫内妊娠物残留15例。分析术中各项指标,术后疗效满意率及随访情况,采用子宫肌瘤症状及健康相关生活质量量表(UFS-QOL)进行症状严重性评分(SSS)与生存质量评分(HRQL)评估。结果:152例手术均成功,无严重并发症发生。手术操作时间4.71±4.60min,术中出血量9±19ml,膨宫液用量603±187ml,疗效满意率达94.7%,SSS评分和HRQL评分术后3个月(14.78±4.3分、78.82±6.31分)、6个月(14.27±3.9分、80.37±5.48分)与术前(30.26±5.7分、65.73±5.26分)比较,均有改善(均P<0.01),术后妊娠率为57.8%,复发率为2.6%。结论:MyoSure治疗宫内良性占位病变安全、有效,结局较理想。Objective: To discuss the safety and effectiveness of the hysteroscopic tissue removal system(MyoSure) for treating intrauterine benign occupying lesions of patients. Methods: A retrospective analysis was carried out on the clinical data of 152 patients with intrauterine benign occupying lesions who had accepted MyoSure treatment from August, 2013 to March, 2023, including 108 patients with submucous uterine myomas, 29 with endometrial polyps and 15 with intrauterine pregnancy residues. The intra-operative indexes, the postoperative satisfaction with the curative effect and the follow-up situation of these patients were analyzed. The uterine fibroid symptoms-health-related quality of life questionnaire(UFS-QOL) was used to evaluate the symptom severity score(SSS) and health related quality of life(HRQL) score of the patients. Results: There were 152 patients with successful operation and without any serious complication. The average operation time, the average bleeding volume, the average uterine distention medium dosage and the satisfaction of the curative effect of the patients were 4.71±4.60 min, 9.11±18.89 ml, 602.63±186.62 ml and 94.7%, respectively. The scores of SSS and HRQL of the patients in 3 months after the operation(14.78±4.3 points and 78.82±6.31 points) and in 6 months after the operation(14.27±3.9 points and 80.37±5.48 points) were significantly higher than those(30.26±5.7 points and 65.73±5.26 points) before the operation(all P<0.01). The rates of the postoperative pregnancy and the recurrence of the patients were 57.8% and 2.6%. Conclusion: MyoSure for treating the intrauterine benign occupying lesions of the patients is safety and effectiveness, and with ideal curative outcomes.

关 键 词：宫腔良性占位病变 宫腔组织切除系统 手术指标 术后妊娠 复发 疗效满意率 

分 类 号：R713.4[医药卫生—妇产科学]